简讯：慢性淋巴细胞白血病
SnapShot: Chronic Lymphocytic Leukemia.
作者信息
Ten Hacken Elisa, Guièze Romain, Wu Catherine J
机构信息
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
CHU Clermont-Ferrand, Hématologie Clinique, Clermont-Ferrand, France.
出版信息
Cancer Cell. 2017 Nov 13;32(5):716-716.e1. doi: 10.1016/j.ccell.2017.10.015.
Abstract
Despite the recent advances in the therapeutic management of Chronic Lymphocytic Leukemia (CLL) patients, this common B cell malignancy still remains incurable. This SnapShot provides an overview of CLL biology and therapy, with a focus on genetics and microenvironmental interactions, which contribute to disease progression and therapy resistance. To view this SnapShot, open or download the PDF.
摘要
尽管在慢性淋巴细胞白血病（CLL）患者的治疗管理方面最近取得了进展，但这种常见的B细胞恶性肿瘤仍然无法治愈。本简要概述提供了CLL生物学和治疗的概述，重点关注遗传学和微环境相互作用，这些因素导致疾病进展和治疗耐药性。要查看此简要概述，请打开或下载PDF。
相似文献
1
SnapShot: Chronic Lymphocytic Leukemia.简讯：慢性淋巴细胞白血病
Cancer Cell. 2017 Nov 13;32(5):716-716.e1. doi: 10.1016/j.ccell.2017.10.015.
2
[Pathogenesis of chronic lymphocytic leukemia].[慢性淋巴细胞白血病的发病机制]
Rinsho Ketsueki. 2015 Mar;56(3):261-8. doi: 10.11406/rinketsu.56.261.
3
SnapShot: chronic lymphocytic leukemia.快照：慢性淋巴细胞白血病。
Cancer Cell. 2014 Nov 10;26(5):770-770.e1. doi: 10.1016/j.ccell.2014.10.020.
4
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.慢性淋巴细胞白血病（CLL）和其他 B 细胞恶性肿瘤的微环境：对疾病生物学的深入了解和新的靶向治疗。
Semin Cancer Biol. 2014 Feb;24:71-81. doi: 10.1016/j.semcancer.2013.08.011. Epub 2013 Sep 7.
5
CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.慢性淋巴细胞白血病的 CD 标志物变化：预后的新见解。
J Cell Physiol. 2019 Nov;234(11):19420-19439. doi: 10.1002/jcp.28724. Epub 2019 May 2.
6
Chronic lymphocytic leukemia: Time to go past genomics?慢性淋巴细胞白血病：是时候超越基因组学了吗？
Am J Hematol. 2016 May;91(5):518-28. doi: 10.1002/ajh.24301. Epub 2016 Apr 4.
7
Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.肝细胞生长因子诱导慢性淋巴细胞白血病的生存及免疫抑制作用
Curr Mol Med. 2017;17(1):24-33. doi: 10.2174/1566524017666170220095838.
8
Novel insights into the biology of CLL.慢性淋巴细胞白血病生物学的新见解。
Hematology Am Soc Hematol Educ Program. 2010;2010:70-6. doi: 10.1182/asheducation-2010.1.70.
9
Chronic lymphocytic leukemia (CLL): a model for understanding and treating chronic B-cell malignancies.慢性淋巴细胞白血病（CLL）：理解和治疗慢性B细胞恶性肿瘤的模型。
Rinsho Ketsueki. 2013 Oct;54(10):1838-42.
10
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.慢性淋巴细胞白血病中的 T 细胞：一把双刃剑。
Front Immunol. 2021 Jan 20;11:612244. doi: 10.3389/fimmu.2020.612244. eCollection 2020.
引用本文的文献
1
PI3K Inhibitors in Hematology: When One Door Closes….PI3K 抑制剂在血液学中的应用：当一扇门关闭时……
Clin Cancer Res. 2024 Sep 3;30(17):3667-3675. doi: 10.1158/1078-0432.CCR-24-0967.
2
Efficacy and safety of ibrutinib in relapsed/refractory CLL and SLL in Japan: a post-marketing surveillance.在日本，ibrutinib 治疗复发/难治性 CLL 和 SLL 的疗效和安全性：一项上市后监测。
J Clin Exp Hematop. 2022 Sep 28;62(3):136-146. doi: 10.3960/jslrt.22002. Epub 2022 Jul 12.
3
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.药物调节 Kv1.3 钾通道选择性地触发遗传 CLL 模型体内病理性 B 淋巴细胞凋亡。
J Exp Clin Cancer Res. 2022 Feb 16;41(1):64. doi: 10.1186/s13046-022-02249-w.
4
Calcium-dependent signalling in B-cell lymphomas.B 细胞淋巴瘤中的钙依赖性信号转导。
Oncogene. 2021 Nov;40(45):6321-6328. doi: 10.1038/s41388-021-02025-8. Epub 2021 Oct 8.
5
Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies.观点：造血系统恶性肿瘤中癌细胞系和正常血细胞系的生物物理调节
APL Bioeng. 2018 May 22;2(3):031802. doi: 10.1063/1.5025689. eCollection 2018 Sep.
本文引用的文献
1
Chronic lymphocytic leukaemia.慢性淋巴细胞白血病。
Nat Rev Dis Primers. 2017 Jan 19;3:16096. doi: 10.1038/nrdp.2016.96.
2
Antigen receptor stereotypy in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的抗原受体刻板性。
Leukemia. 2017 Feb;31(2):282-291. doi: 10.1038/leu.2016.322. Epub 2016 Nov 4.
3
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.慢性淋巴细胞白血病患者对 BTK 抑制产生耐药性后的克隆进化。
Nat Commun. 2016 May 20;7:11589. doi: 10.1038/ncomms11589.
4
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.慢性淋巴细胞白血病新型疗法的临床前建模：行业工具
Semin Oncol. 2016 Apr;43(2):222-32. doi: 10.1053/j.seminoncol.2016.02.007. Epub 2016 Feb 8.
5
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.B细胞成熟过程中的DNA甲基化动态变化是慢性淋巴细胞白血病一系列疾病表型的基础。
Nat Genet. 2016 Mar;48(3):253-64. doi: 10.1038/ng.3488. Epub 2016 Jan 18.
6
Mutations driving CLL and their evolution in progression and relapse.驱动慢性淋巴细胞白血病的突变及其在疾病进展和复发中的演变。
Nature. 2015 Oct 22;526(7574):525-30. doi: 10.1038/nature15395. Epub 2015 Oct 14.
7
Non-coding recurrent mutations in chronic lymphocytic leukaemia.慢性淋巴细胞白血病中的非编码重现性突变。
Nature. 2015 Oct 22;526(7574):519-24. doi: 10.1038/nature14666. Epub 2015 Jul 22.
8
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician.进入慢性淋巴细胞白血病的靶向治疗时代：对临床执业医师的影响
J Clin Oncol. 2014 Sep 20;32(27):3039-47. doi: 10.1200/JCO.2014.55.8262.
9
Cellular origin and pathophysiology of chronic lymphocytic leukemia.慢性淋巴细胞白血病的细胞起源和病理生理学。
J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22.
10
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.慢性淋巴细胞白血病诊断与治疗指南：慢性淋巴细胞白血病国际研讨会报告，更新美国国立癌症研究所工作组1996年指南
Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23.
Zotero 插件